Search

everythinglearnresearchcommunity

for

Search:↓

Regenerative treatments for vitiligo show promise but need more research for long-term safety and effectiveness.

Alopecia areata in Taif is common, mainly immune-related, and best treated with topical corticosteroids and vitamins.

Hair follicles are key to treating vitiligo and alopecia areata, but challenges exist.

Vitiligo often starts young, is linked to family history and stress, and requires comprehensive care including psychological support.

taVNS reduces vitiligo symptoms in mice.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Certain gene variations may increase the risk and severity of alopecia areata.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

Children with HIV often have skin problems that can indicate the severity of their immune system damage.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

Tretinoin gel is safe for sun exposure, but tacalcitol doesn't significantly improve non-segmental vitiligo.

Kids with alopecia areata had lower vitamin D levels than healthy kids.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Weekly azathioprine pulse is a better alternative to corticosteroids for treating alopecia areata due to fewer side effects.

Microneedles improve drug delivery for skin diseases, enhancing treatment effectiveness and patient compliance.

Granzyme B is important in autoimmune skin diseases and could be a new treatment target.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Targeting psychosocial factors can help reduce self-stigma in people with chronic skin diseases.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

Trichoscopy helps diagnose and monitor hair and scalp problems without needing many biopsies.

Phenol is effective for skin treatments but poses serious health risks and must be used cautiously by trained doctors.

Regenerative medicine shows promise for treating skin disorders like hair loss and vitiligo.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Mitochondrial dysfunction is linked to various skin conditions and could be a target for treatments.